Closed-loop therapy in older adults with type 1 diabetes: hypoglycaemia benefits and risk stratification – Authors' reply
Year: 2022
Type: letter
Abstract: We thank Sybil McAuley and Steven Trawley for bringing the recently published results of the ORACL trial1 to our attention and apologise for not including their work in our recent Comment.2 In this study, they and their colleagues report that, relative to sensor-augmented pump therapy, a hybrid closed-loop insulin delivery strategy was associated with significant improvements in time in range measured by continuous glucose monitoring in older adults with type 1 diabetes. Moreover, and in contrast to the study of Charlotte Boughton and colleagues,3 they report small but significant decreases in hypoglycaemia with a hybrid closed-loop strategy.
Source: The Lancet Healthy Longevity
Authors: Richard E Pratley, Anna Casu
Institutions: Johns Hopkins University, AdventHealth Orlando, AdventHealth
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,500
OpenAlex ID: W4286885781